JHS Svendgaard Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
JHS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
JHS Svendgaard Laboratories Limited has filed its financial results with the NSE for the quarter and nine months ended December 31, 2025. The filing covers the company's Q3 FY26 (or the third quarter of its ongoing financial year) standalone and/or consolidated performance. No specific revenue, profit, or margin figures were disclosed in the filing notice itself; investors will need to review the detailed results document. The submission keeps the company compliant with NSE listing requirements on timely disclosure.
For shareholders, this is a routine compliance filing rather than a material event, so no immediate price action is expected from the announcement alone. The actual stock reaction will depend on the numbers inside the results — look for revenue trends, margin movement, and profit growth versus the year-ago quarter.